Table 1.
Summary of the serum samples used for probing C. burnetii peptide microarrays.
| Group | n | Vaccination status | Challenge status | Reference | |
|---|---|---|---|---|---|
| Cattle | NEG | 10 | Unvaccinated | Unchallenged | (51) |
| POS | 10 | Unvaccinated | Natural exposure | (52) | |
| Goat | NEG | 10 | Unvaccinated | Unchallenged | (53, 54) |
| UV+C | 10 | Unvaccinated | Challenged with C. burnetii strain X09003262-001 | (54) | |
| PV1 | 10 | Coxevac® PhI WCV | Unchallenged | (55) | |
| Human | NEG | 15 | Unvaccinated | Unchallenged | (56) |
| POS | 15 | Unvaccinated | Natural exposure | (56) | |
| Sheep | NEG | 18 | Unvaccinated | Unchallenged | (26) |
| PV1 | 20 | Coxevac® PhI WCV | Unchallenged | (26) | |
| PV1+C | 6 | Coxevac® PhI WCV | Challenged with C. burnetii strain Nine Mile RSA493 | (26) | |
| PV2 | 20 | PhII WCV | Unchallenged | (26) | |
| PV2+C | 6 | PhII WCV | Challenged with C. burnetii strain Nine Mile RSA493 | (26) | |
| UV+C | 6 | Unvaccinated | Challenged with C. burnetii strain Nine Mile RSA493 | (26) |
PhI WCV, C. burnetii phase I whole-cell vaccine; PhII WCV, C. burnetii phase I whole-cell vaccine.